Analyst: Listed subsidiary may pave the way for WSA and take chunk out of massive debt

WS Audiology's subsidiary going public could shave down a sizeable chunk of the hearing aid firm's billion kroner debt, according to a CIB analyst. He notes that when the subsidiary goes public this will generate positive attention around WSA which can positively impact the possibility of WSA getting listed.

Photo: WS Audiology / PR

On Tuesday, Danish hearing aid company WS Audiology garnered attention due to its announcement that it would be taking its Dutch-domiciled subsidiary public on the US stock exchange.

Carnegie Investment Bank Head of Equity Research and long-time hearing industry analyst Niels Granholm-Leth holds that this decision is rooted in some rational explanations.

Read the whole article

Get 14 days free access.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Pfizer upgrades guidance for sales of covid-19 vaccine

The US pharmaceutical company Pfizer now predicts sales of its coronavirus vaccines will total USD 33.5bn this year. The previous estimate was UDS 26bn. Meanwhile, the company has revealed the guidance for its annual revenue.

Further reading

Related articles

Trial banner

Latest news

See all jobs